Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €87.00 ($102.35) target price from research analysts at Commerzbank Ag in a report issued on Thursday. The firm currently has a “neutral” rating on the stock.

FME has been the subject of several other research reports. Citigroup Inc. set a €92.00 ($108.24) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Tuesday, August 8th. Deutsche Bank AG set a €85.00 ($100.00) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a research report on Wednesday, August 2nd. Kepler Capital Markets set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Monday, July 24th. Finally, Independent Research GmbH set a €88.00 ($103.53) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a research report on Tuesday, August 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of €89.12 ($104.84).

ILLEGAL ACTIVITY NOTICE: “Fresenius Medical Care AG & Co. (Pref) (FME) PT Set at €87.00 by Commerzbank Ag” was first reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/02/fresenius-medical-care-ag-87-00-by-commerzbank-ag.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.